Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair
Authors:
Open Access
- 24 April 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 5, 110
Abstract
Recent advances in the differentiation and production of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) have stimulated development of strategies to use these cells in human cardiac regenerative therapies. A prerequisite for clinical trials and translational implementation of hPSC-derived CMs is the ability to manufacture safe and potent cells on the scale needed to replace cells lost during heart disease. Current differentiation protocols generate fetal-like CMs that exhibit proarrhythmogenic potential. Sufficient maturation of these hPSC-derived CMs has yet to be achieved to allow these cells to be used as a regenerative medicine therapy. Insights into the native cardiac environment during heart development may enable engineering of strategies that guide hPSC-derived CMs to mature. Specifically, considerations must be made in regards to developing methods to incorporate the native intercellular interactions and biomechanical cues into hPSC-derived CM production that are conducive to scale-up.Keywords
Funding Information
- National Institutes of Health (R01EB007534, T32 GM008505)
- National Science Foundation (1547225, 1743346, 1648035)
This publication has 123 references indexed in Scilit:
- Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNACell Research, 2013
- Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte MonolayersCirculation Research, 2012
- Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProceedings of the National Academy of Sciences, 2012
- Distinct Compartments of the Proepicardial Organ Give Rise to Coronary Vascular Endothelial CellsDevelopmental Cell, 2012
- Growth of Engineered Human Myocardium With Mechanical Loading and Vascular CocultureCirculation Research, 2011
- Cryopreservation of Human Stem Cells for Clinical Application: A ReviewTransfusion Medicine and Hemotherapy, 2011
- Non-Cardiomyocytes Influence the Electrophysiological Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes During DifferentiationStem Cells and Development, 2010
- Absence of Transverse Tubules Contributes to Non-Uniform Ca 2+ Wavefronts in Mouse and Human Embryonic Stem Cell–Derived CardiomyocytesStem Cells and Development, 2009
- Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissueProceedings of the National Academy of Sciences, 2009
- Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytesCardiovascular Research, 2009